AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript
ABCL earnings call for the period ending December 31, 2023.
Stay updated with breaking news from Trianni Mouse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ABCL earnings call for the period ending December 31, 2023.
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript February 20, 2024 AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. AbCellera Biologics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. […]
The Trianni Mouse®, AbCellera’s technology for generating large databases of human antibodies for drug discovery programs, is granted United States patentVANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibod...